Home › Lung Cancer › New York › Queens
Lung Cancer clinical trials in Queens, NY
22 studies for Lung Cancer are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
RecruitingPhase 2
- MSK Nassau, Uniondale · 13 mi away
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi away
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecruitingPhase 3
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
A Registry for People With Lung Cancer
RecruitingObservational study
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
RecruitingPhase 2/3
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi away
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecruitingPhase 1
- NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola · 11 mi away
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 3
- Clinical Research Alliance, Westbury · 14 mi away
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi away
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi away
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecruitingPhase 1
- NYU Langone Health - Long Island, Mineola · 11 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Queens Hospital Center, Jamaica · 2 mi away
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
RecruitingPhase 3
- Northwell Health/R.J. Zuckerberg Cancer Center, Lake Success · 9 mi away
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
RecruitingPhase 3
- Optum Medical Care, PC, Westbury · 14 mi away
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RecruitingPhase 3
- NYU Langone Hospital - Long Island, Mineola · 11 mi away
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecruitingPhase 3
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi away
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
A Study of Lung Cancer Risk
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi away
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Recruiting
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre · 10 mi away
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RecruitingPhase 1/2
- Clinical Research Alliance, Westbury · 14 mi away
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
RecruitingPhase 2
- Memorial Sloan Kettering Nassau, Rockville Centre · 10 mi away
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RecruitingObservational study
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Hempstead · 12 mi away
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
RecruitingPhase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Arlington, VA40 studies
- Baltimore, MD40 studies
- Nashville, TN40 studies
- St. Louis, MO39 studies
- Columbus, OH36 studies
- Philadelphia, PA36 studies
Other studies in Queens
- Breast Cancer63 studies
- Non-Small Cell Lung Cancer49 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Ovarian Cancer28 studies
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Endometrial Cancer26 studies
- Acute Myeloid Leukemia21 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Pancreatic Cancer20 studies
- Multiple Myeloma20 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.